tiprankstipranks
Trending News
More News >
Cns Pharmaceuticals, Inc. (CNSP)
NASDAQ:CNSP
US Market

CNS Pharmaceuticals (CNSP) Income Statement

Compare
1,088 Followers

CNS Pharmaceuticals Income Statement

Last quarter (Q3 2025), CNS Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, CNS Pharmaceuticals's net income was $-3.22M. See CNS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.31K$ -4.13K$ -11.76K$ -13.07K$ -11.10K
Operating Expenses
$ 14.90M$ 18.86M$ 14.92M$ 14.47M$ 9.44M
Depreciation and Amortization
$ 3.31K$ 4.13K$ 11.76K$ 13.07K$ 11.10K
EBITDA
$ -14.84M$ -18.86M$ -15.26M$ -14.47M$ -9.44M
Operating Income
$ -14.90M$ -18.87M$ -14.93M$ -14.49M$ -9.45M
Other Income/Expenses
$ 44.14K$ 13.88K$ -341.17K$ -9.29K$ -3.26K
Pretax Income
$ -14.86M$ -18.85M$ -15.27M$ -14.50M$ -9.46M
Net Income
$ -14.86M$ -18.85M$ -15.27M$ -14.50M$ -9.46M
Per Share Metrics
Basic EPS
$ -38.87$ -60.00$ -134.64$ -6.36$ -6.84
Diluted EPS
$ -38.87$ -60.00$ -134.64$ -6.36$ -6.84
Weighted Average Shares Outstanding
317.26K 6.22M 2.26M 1.41M 913.00K
Weighted Average Shares Outstanding (Diluted)
317.26K 6.22M 2.26M 1.46M 919.56K
Currency in USD

CNS Pharmaceuticals Earnings and Revenue History